MEDICINA
Departamento
Instituto Universitario de Oncologia del Principado de Asturias
Oviedo, EspañaPublicaciones en colaboración con investigadores/as de Instituto Universitario de Oncologia del Principado de Asturias (17)
2024
-
Outcomes after intensive chemotherapy for secondary and myeloid-related changes acute myeloid leukemia patients aged 60 to 75 years old: a retrospective analysis from the PETHEMA registry
Haematologica, Vol. 109, Núm. 1, pp. 115-128
-
Penetrance of Dilated Cardiomyopathy in Genotype-Positive Relatives
Journal of the American College of Cardiology, Vol. 83, Núm. 17, pp. 1640-1651
2023
-
Genomics improves risk stratifi cation of adults with T-cell acute lymphoblastic leukemia enrolled in measurable residual disease-oriented trials
Haematologica, Vol. 108, Núm. 4, pp. 969-980
-
Procalcitonin and C-reactive protein to rule out early bacterial coinfection in COVID-19 critically ill patients
Intensive Care Medicine, Vol. 49, Núm. 8, pp. 934-945
-
The Oncogenic FOXL2 C134W Mutation Is a Key Driver of Granulosa Cell Tumors
Cancer research, Vol. 83, Núm. 2, pp. 239-250
2022
-
ICU-Acquired Pneumonia Is Associated with Poor Health Post-COVID-19 Syndrome
Journal of Clinical Medicine, Vol. 11, Núm. 1
-
Major candidate variables to guide personalised treatment with steroids in critically ill patients with COVID-19: CIBERESUCICOVID study
Intensive Care Medicine, Vol. 48, Núm. 7, pp. 850-864
-
Methodology of a Large Multicenter Observational Study of Patients with COVID-19 in Spanish Intensive Care Units
Archivos de Bronconeumologia, Vol. 58, pp. 22-31
-
Prognostic implications of comorbidity patterns in critically ill COVID-19 patients: A multicenter, observational study
The Lancet Regional Health - Europe, Vol. 18
2021
-
Correction to: The evolution of the ventilatory ratio is a prognostic factor in mechanically ventilated COVID-19 ARDS patients (Critical Care, (2021), 25, 1, (331), 10.1186/s13054-021-03727-x)
Critical Care
-
The evolution of the ventilatory ratio is a prognostic factor in mechanically ventilated COVID-19 ARDS patients
Critical Care, Vol. 25, Núm. 1
2020
-
Circulating tumor cells for comprehensive and multiregional non-invasive genetic characterization of multiple myeloma
Leukemia, Vol. 34, Núm. 11, pp. 3007-3018
-
Daratumumab is a safe and effective rescue therapy for multiple myeloma patients who relapse after allo-HSCT
Bone Marrow Transplantation
2018
-
Basophil-lineage commitment in acute promyelocytic leukemia predicts for severe bleeding after starting therapy
Modern Pathology, Vol. 31, Núm. 8, pp. 1318-1331
2015
-
Non-coding recurrent mutations in chronic lymphocytic leukaemia
Nature, Vol. 526, Núm. 7574, pp. 519-524
2014
-
Mutations in TLR/MYD88 pathway identify a subset of young chronic lymphocytic leukemia patients with favorable outcome
Blood, Vol. 123, Núm. 24, pp. 3790-3796
2013
-
Landscape of somatic mutations and clonal evolution in mantle cell lymphoma
Proceedings of the National Academy of Sciences of the United States of America, Vol. 110, Núm. 45, pp. 18250-18255